Abstract
A centrally acting antitussive agent dextromethorphan (DM) was tested to determine its possible interaction with naloxone in rats responding under a fixed-interval schedule of positive reinforcement. A sugar sweetened milk reward was used as a positive reinforcer. Under the same experimental conditions the effects of morphine alone and in combination with naloxone were also determined. Low dose DM (10 mg/kg) produced a slight increase, while higher doses (20–40 mg/kg) produced dose-dependent decreases in response rate. Morphine (0.3, 1.0 and 3.0 mg/kg) produced dose-dependent decreases in response rate. When doses of naloxone (0.1–1.0 mg/kg) were administered after the injection of DM the rate-decreasing effects of DM were potentiated even after the rate-increasing dose of naloxone (0.1 mg/kg) was used. When a dose of naloxone (0.1 mg/kg) was administered after the injection of morphine the rate-decreasing effects of morphine were markedly antagonized, i.e., the morphine dose-response curve was shifted to the right. The observed potentiation of DM disruption by naloxone on fixed-interval performance in rats is consistent with findings showing that naloxone potentiates the disruptive behavioral effects of a number of drugs that are psychotomimetic in man.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brady KT, Balster RL, May EL (1982) Stereoisomers of N-allylnormetazocine: Phencyclidine-like behavioral effects in squirrel monkeys and rats. Science 215:178–180
Brady LS, Holtzman SG (1981) Effects of intraventricular morphine and enkephalins on schedule-controlled behavior in nondependent, morphine-dependent and post-dependent rats. J Pharmacol Exp Ther 219:344–357
Chang KJ, Cuatrecasas P (1981) Heterogeneity and properties of opiate receptors. Fed Proc 40:2729–2734
Commissaris R, Moore K, Rech R (1980) Naloxone potentiates the disruptive effects of mescaline on operant responding in the rat. Pharmacol Biochem Behav 13:601–603
Craviso GL, Musacchio JM (1983a) High-affinity dextromethorphan binding sites in guinea pig brain. Mol Pharmacol 23:619–628
Craviso GL, Musacchio JM (1983b) High-affinity dextromethorphan binding sites in guinea pig brain. Mol Pharmacol 23:629–640
Dhawan BN, Gupta GP (1959) LSD-25 antagonism of morphine analgesia. Arch Int Pharmacodyn 123:132–139
Dhawan BN, Gupta GP (1961) Antiemetic activity of D-lysergic acid diethylamide. J Pharmacol Exp Ther 133:137–139
Domino EF (1964) Neurobiology of phencyclidine (sernyl), a drug with an unusual spectrum of pharmacologic activity. Int Rev Neurobiol 6:303–347
Fertziger R, Fisher R (1977) Interaction between narcotic antagonists (naloxone) and lysergic acid diethylamide (LSD) in the rat. Psychopharmacology 54:313–314
Hadorn DC, Anistranski JA, Connor JD (1984) Influence of naloxone on the effects of LSD in monkeys. Neuropharmacology 23:1297–1300
Haertzen CA (1970) Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI). Psychopharmacology 18:366–377
Haigler HJ (1978) Morphine: effects of serotonergic neurons and neurons in areas with a serotonergic input. Eur J Pharmacol 51:361–376
Haigler HJ, Spring DD (1979) Drugs that antagonize limb flick behavior induced by D-lysergic acid diethylamine (LSD) in cats. Psychopharmacolgy 64:31–34
Harris RA (1980) Interaction between narcotic agonists, partial agonists, and antagonists evaluated by schedule controlled behavior. J Pharmacol Exp Ther 213:497–503
Herling S, Woods JH (1981) Discriminative stimulus effects of narcotics: evidence for multiple receptor mediated actions. Life Sci 28:1571–1584
Herling S, Winger GD, Coale EH, Hein DW, Woods JH (1980) Similarity of the discriminative stimulus effects of dextrorphan, ketamine, and cyclazocine in the pigeon. Fed Proc 39:994
Herling S, Solomon RE, Woods JH (1983) Discriminative stimulus effects of dextrorphan in pigeons. J Pharmacol Exp Ther 227:723–731
Holtzman SG (1980) Phencyclidine-like discriminative effects of opioids in the rat. J Pharmacol Exp Ther 214:614–619
Jasinski DR, Martin WR, Mansky PA (1971) Progress report on the assessment of the antagonist nalbuphine and GPA-2087 for abuse potential and studies of the effects of dextromethorphan in man. Reported to the 33rd Meeting, Committee on Problems of Drug Dependence, Toronto, Canada, National Academy of Sciences/National Research Council, Vol. 1, 143–178
Jasinski DR, Martin WR, Sapira JD (1968) Antagonism of the subjective behavioral, pupillary and respiratory depressant effects of cyclazocine by naloxone. Clin Pharmacol Ther 9:215–222
Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532
McMillan DE (1969) Behavioral interactions of naloxone with morphine and cyclazocine in the pigeon. Fed Proc 28:736
McMillan DE, Wolf PS, Carchman RA (1970) Antagonism of the behavioral effects of morphine and methadone by narcotic antagonists in the pigeon. J Pharmacol Exp Ther 175:443–458
McNicholas LF, Martin WR (1984) New and experimental therapeutic roles for naloxone and related opioid antagonists. Drugs 27:81–93
Ruffing D, Domino EF (1981) Effects of selected opioid agonists and antagonists on DMT and LSD-25 induced disruption of bar pressing behavior in the rat. Psychopharmacology 75:226–230
Ruffing D, Kovacic B, Demetriou S, Domino EF (1979) Naloxone enhancement of DMT induced suppression of food-rewarded bar pressing behavior in the rat. Psychopharmacology 62:207–210
Shannon HE (1981) Evaluation of phencyclidine analogues on the basis of their discriminative stimulus properties in the rat. J Pharmacol Exp Ther 216:543–553
Shannon HE (1982) Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats. J Pharmacol Exp Ther 222:146–151
Teal JJ, Holtzman SG (1980) Stereoselectivity of the stimulus effects of morphine and cyclazocine in the squirrel monkey. J Pharmacol Exp Ther 215:369–376
Vincent JP, Kartalovski B, Geneste P, Kamenka JM, Lazdunski M (1979) Interaction of phencyclidine (“angel dust”) with a specific receptor in rat brain membranes. Proc Natl Acad Sci USA 76:4678–4682
Wagner GC, Masters DB, Tomie A (1984) Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats. Psychopharmacology 84:32–38
Woods JH (1969) Effects of morphine, methadone and codeine on schedule-controlled behavior in the pigeon. Fed Proc 28:511
Wu KM, Martin WR (1982) Effects of naloxone and fentanyl in acutely decerebrated dog. Life Sci 31:151–157
Zukin SR, Zukin RS (1979) Specific (3H)-phencyclidine binding in rat central nervous system. Proc Natl Acad Sci USA 76:5372–5376
Zukin SR, Zukin RS (1980) (3H)-phencyclidine binding to specific brain receptor sites. Psychopharmacology Bull 16:59–62
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taşkin, T. Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats. Psychopharmacology 90, 408–411 (1986). https://doi.org/10.1007/BF00179200
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00179200